U.S. employers say they’re expecting their total health benefits plan costs to rise by an average of 5.4 per cent per employee in 2024, according to a new survey by Mercer. The survey, which polled more than 1,900 employers, found the projected increase comes after more than a decade of annual cost increases typically averaging […]
U.S. employers are expecting health benefits costs to increase by an average of 8.5 per cent to more than $15,000 per employee in 2024, according to a new survey by Aon. The survey, which polled 800 U.S. employers, found the projected increase is nearly double the budgeted amount that employers experienced from 2022 to 2023 (4.5 per cent). […]
The costs of U.S. employer-sponsored medical benefits are expected to rise seven per cent in 2024, according to a new survey by the International Foundation of Employee Benefit Plans. The survey found 79 per cent of U.S. employers’ benefits plans are self-funded (with or without stop-loss coverage), while 21 per cent are fully insured. The […]
Running for more than 17 years, Benefits Canada‘s Face to Face Drug Plan Management Forum is the industry’s most popular drug benefits conference. In 2022, the event returned to a face-to-face format at the Sheraton Centre in Toronto on Dec. 6. Attendees learned about fresh drug plan design insights, including a new drug launch panel […]
With cost of private drug plan claims rising about 5.5 per cent each year, pooling is one solution that could be beneficial for benefits plan sponsors. “Theoretically, if these claims could be shared across a broader group, such as the complete private insurance industry, plan costs could be less volatile for individual plan sponsors,” said […]
Plan sponsors face challenges balancing benefits plan sustainability while also ensuring their plan members have access to the care they need, said Marie-Hélène Dugal, manager of pharmacy benefit strategy at Medavie Blue Cross, during a session at Benefits Canada’s 2022 Face to Face Drug Plan Management Forum in Toronto in December. Referring to Medavie’s claims data, […]
With the cost of drug claims continuing to rise in 2021, benefits plan sponsors can enable certain drug programs to curb costs, keeping their plans sustainable and offering the benefits that members highly value, said Lavina Viegas, director of pharmacy operations at Telus Health, during a session at Benefits Canada’s 2022 Face to Face Drug […]
About a million Canadians are impacted by rare diseases, which disproportionately affect younger patients — 70 per cent start in childhood and, sadly, half of these children won’t reach adulthood, said Suzanne Lepage, a private health plan strategist, during a session supported by Alexion Pharmaceuticals at Benefits Canada‘s 2022 Face to Face Drug Plan Management Forum […]
While vaccine coverage varies across provincial drug plans, several million Canadians who are members of private drug plans don’t have coverage at all, according to Chris Bonnett (pictured left), founder and principal consultant of H3 Consulting, during a panel session supported by GSK, Merck & Co. Inc. and Pfizer Canada Inc. at Benefits Canada’s 2022 […]
Average benefits costs for U.S. employers will increase 6.5 per cent — or more than $13,800 per employee — in 2023, according to a new report by Aon. This projection is more than double the three per cent increase to health-care budgets from 2021 to 2022, but below the 9.1 inflation figure reported through the consumer price […]